ACE2 and COVID-19: In silico comparison of the angiotensin-converting enzyme 2 (ACE2) sequence of humans with that of hamsters predicted that the SARS-CoV-2 S protein RBD would effectively bind hamster ACE2 [17], and provide a relevant animal model for COVID-19.